Clinical Trial Detail

NCT ID NCT03707938
Title Local Consolidative Therapy and Brigatinib in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements yes
Sponsors M.D. Anderson Cancer Center
Indications

non-small cell lung carcinoma

Therapies

Brigatinib

Age Groups: adult senior

Additional content available in CKB BOOST